Obestatin signalling counteracts glucocorticoid‐induced skeletal muscle atrophy via NEDD4/KLF15 axis

BACKGROUND: A therapeutic approach for the treatment of glucocorticoid‐induced skeletal muscle atrophy should be based on the knowledge of the molecular mechanisms determining the unbalance between anabolic and catabolic processes and how to re‐establish this balance. Here, we investigated whether t...

Descripción completa

Detalles Bibliográficos
Autores principales: Cid‐Díaz, Tania, Leal‐López, Saúl, Fernández‐Barreiro, Fátima, González‐Sánchez, Jessica, Santos‐Zas, Icía, Andrade‐Bulos, Luis J., Rodríguez‐Fuentes, Manuel E., Mosteiro, Carlos S., Mouly, Vincent, Casabiell, Xesús, Relova, Jose Luis, Pazos, Yolanda, Camiña, Jesus P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061369/
https://www.ncbi.nlm.nih.gov/pubmed/33687156
http://dx.doi.org/10.1002/jcsm.12677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061369/
https://www.ncbi.nlm.nih.gov/pubmed/33687156
http://dx.doi.org/10.1002/jcsm.12677

Ejemplares similares